Replimune Group, Inc. (REPL)

3.34 -0.10 (-2.91%) USD  |  NASDAQ  |  May 07, 16:00
3.33 -0.01 (-0.30%) Pre-Market: 08:40
More

Replimune Group Total Operating Expenses (TTM)

Total Operating Expenses (TTM) Chart

View Total Operating Expenses (TTM) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (TTM) Range, Past 5 Years

View Total Operating Expenses (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (TTM) Benchmarks

View Total Operating Expenses (TTM) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
REGENXBIO, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade